![Robert Lisicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Lisicki
Corporate Officer/Principal chez
ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
Robert Lisicki is Chief Commercial Officer & Executive VP at Arcutis Biotherapeutics, Inc. since 2026.
Formerly, Mr. Lisicki was Chief Executive Officer & Director at Zura Bio Ltd. from 2024 to 2025, Independent Director at Cadrenal Therapeutics, Inc. from 2023 to 2025, Director at Adiso Therapeutics, Inc. from 2023 to 2024, Chief Executive Officer & Director at InCarda Therapeutics, Inc. from 2022 to 2023, Chief Commercial Officer & Executive VP at Arena Pharmaceuticals, Inc. from 2018 to 2022, Chief Customer Officer, SVP-Sales & Marketing at Daiichi Sankyo, Inc. from 2014 to 2018, Vice President & General Manager at Amgen, Inc. from 2005 to 2014, and General Manager & Vice President-Cardio Metabolic at Regeneron Pharmaceuticals, Inc. Education includes undergraduate studies at State University of New York at Albany.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Robert Lisicki
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 17/08/2026 |
Anciens postes connus de Robert Lisicki
| Sociétés | Poste | Fin |
|---|---|---|
| ZURA BIO LIMITED | Directeur Général | 10/10/2025 |
| CADRENAL THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/07/2025 |
Adiso Therapeutics, Inc.
 Adiso Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology research services | Directeur/Membre du Conseil | 01/08/2024 |
InCarda Therapeutics, Inc.
 InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders | Directeur Général | 01/03/2023 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/03/2022 |
Formation de Robert Lisicki
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
InCarda Therapeutics, Inc.
InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders | Commercial Services |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Adiso Therapeutics, Inc.
Adiso Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Cadrenal Therapeutics, Inc.
 Cadrenal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel therapy with orphan drug indication | Health Technology |
